This review systematically examines the varied effects of GLP-1RAs on the risk of different types of tumors, including overall cancer risk and specific cancers such as thyroid, pancreatic, reproductive system, liver, and colorectal cancers
Titration escalates in 0.250.5 mg increments weekly or bi-weekly, with most therapeutic ranges reaching 2.03.0 mg based on individual tolerance and provider assessment
Long-term use requires regular monitoring of: Heart rate and blood pressure Mood changes, including suicidal thoughts Blood sugar, especially in people with type 2 diabetes Kidney function and risk of kidney stones Signs of metabolic acidosis Thyroid function Body temperature regulation and hydration Common and Serious Side Effects Common Side Effects of Qsymia These are often dose-related and may improve over time: Dry mouth Constipation Trouble sleeping Tingling in hands or feet Dizziness Headache Upper respiratory tract infection Changes in taste Serious Side Effects Although less common, these require immediate medical advice: Mood changes or suicidal thoughts Increased heart rate Vision problems related to glaucoma Metabolic acidosis Severe skin reactions Allergic reaction Kidney stones, especially in people prone to them Because topiramate is a carbonic anhydrase inhibitor, it can affect acid-base balance and kidney function, particularly in people on dialysis or with other health conditions
You may find that you no longer spend your whole day thinking about your next meal
